Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1973 2
1974 18
1975 10
1976 7
1977 23
1978 11
1979 20
1980 18
1981 20
1982 32
1983 33
1984 22
1985 49
1986 35
1987 39
1988 43
1989 56
1990 54
1991 55
1992 68
1993 80
1994 73
1995 108
1996 105
1997 110
1998 153
1999 129
2000 112
2001 117
2002 115
2003 122
2004 105
2005 115
2006 100
2007 130
2008 96
2009 79
2010 77
2011 109
2012 113
2013 104
2014 103
2015 116
2016 82
2017 79
2018 56
2019 67
2020 69
2021 29
Text availability
Article attribute
Article type
Publication date

Search Results

3,322 results
Results by year
Filters applied: . Clear all
Page 1
Randomized Trial of Amoxicillin for Pneumonia in Pakistan.
Jehan F, Nisar I, Kerai S, Balouch B, Brown N, Rahman N, Rizvi A, Shafiq Y, Zaidi AKM. Jehan F, et al. N Engl J Med. 2020 Jul 2;383(1):24-34. doi: 10.1056/NEJMoa1911998. N Engl J Med. 2020. PMID: 32609980 Free PMC article. Clinical Trial.
BACKGROUND: The World Health Organization (WHO) recommends oral amoxicillin for patients who have pneumonia with tachypnea, yet trial data indicate that not using amoxicillin to treat this condition may be noninferior to using amoxicillin. ...The primary outc …
BACKGROUND: The World Health Organization (WHO) recommends oral amoxicillin for patients who have pneumonia with tachypnea, yet trial …
Bioequivalence of generic and branded amoxicillin capsules in healthy human volunteers.
Pathak P, Pandit VA, Dhande PP. Pathak P, et al. Indian J Pharmacol. 2017 Mar-Apr;49(2):176-181. doi: 10.4103/ijp.IJP_793_16. Indian J Pharmacol. 2017. PMID: 28706331 Free PMC article. Clinical Trial.
AIM: This study was planned to ascertain whether bioequivalence of branded and generic amoxicillin capsule is comparable. SETTINGS AND DESIGN: An open-label, randomized, single-dose, two-treatment, two-sequence, two-period crossover oral bioequivalence study was conducted …
AIM: This study was planned to ascertain whether bioequivalence of branded and generic amoxicillin capsule is comparable. SETTINGS AN …
Amoxicillin for 3 or 5 Days for Chest-Indrawing Pneumonia in Malawian Children.
Ginsburg AS, Mvalo T, Nkwopara E, McCollum ED, Phiri M, Schmicker R, Hwang J, Ndamala CB, Phiri A, Lufesi N, May S. Ginsburg AS, et al. N Engl J Med. 2020 Jul 2;383(1):13-23. doi: 10.1056/NEJMoa1912400. N Engl J Med. 2020. PMID: 32609979 Free PMC article. Clinical Trial.
Children not infected with human immunodeficiency virus (HIV) who were 2 to 59 months of age and had chest-indrawing pneumonia were randomly assigned to receive amoxicillin twice daily for either 3 days or 5 days. Children were followed for 14 days. ...CONCLUSIONS: In HIV- …
Children not infected with human immunodeficiency virus (HIV) who were 2 to 59 months of age and had chest-indrawing pneumonia were randomly …
Multiple-dose pharmacokinetics and safety of amoxicillin/clavulanate in healthy elderly subjects.
Lee SW, Choi Y, Jang K, Yoon SH, Chung JY. Lee SW, et al. Int J Clin Pharmacol Ther. 2020 Nov;58(11):634-641. doi: 10.5414/CP203773. Int J Clin Pharmacol Ther. 2020. PMID: 32729824 Clinical Trial.
BACKGROUND: Amoxicillin/clavulanate is a widely used oral formulation of penicillin combined with a beta-lactamase inhibitor. When using amoxicillin/clavulanate in the elderly, the risk of adverse drug reaction may be greater. ...
BACKGROUND: Amoxicillin/clavulanate is a widely used oral formulation of penicillin combined with a beta-lactamase inhibitor. When us …
Urinary concentrations and bactericidal activity against amoxicillin-nonsusceptible strains of Escherichia coli with single-dose, oral, sustained-release amoxicillin/clavulanic acid: a phase I, open-label, noncomparative clinical trial in healthy volunteers.
Ponte C, Gracia M, Giménez MJ, Aguilar L, Maín CM, Carpintero Y, Huelves L, Carcas A, del Prado G, Soriano F. Ponte C, et al. Clin Ther. 2005 Jul;27(7):1043-9. doi: 10.1016/j.clinthera.2005.07.001. Clin Ther. 2005. PMID: 16154483 Clinical Trial.
METHODS: This Phase I, open-label, noncomparative study in healthy male volunteers was conducted at the Pharmacology Unit, Autonoma University, Madrid, Spain. Subjects received a single oral dose of amoxicillin/clavulanic acid 2000/125 mg SR. The amoxicillin/clavula …
METHODS: This Phase I, open-label, noncomparative study in healthy male volunteers was conducted at the Pharmacology Unit, Autonoma Universi …
Comparative trial between the use of amoxicillin and amoxicillin clavulanate in the removal of third molars.
Iglesias-Martín F, García-Perla-García A, Yañez-Vico R, Aced-Jiménez E, Arjona-Gerveno E, González-Padilla JD, Gutierrez-Pérez JL, Torres-Lagares D. Iglesias-Martín F, et al. Med Oral Patol Oral Cir Bucal. 2014 Nov 1;19(6):e612-5. doi: 10.4317/medoral.19778. Med Oral Patol Oral Cir Bucal. 2014. PMID: 24880449 Free PMC article. Clinical Trial.
OBJECTIVE: The purpose of this study was to compare the use of amoxicillin (1g) vs amoxicillin and clavulanate (875/125mg) after extraction of retained third molars for prevention of infectious complications. ...CONCLUSION: The results of our study show that the use …
OBJECTIVE: The purpose of this study was to compare the use of amoxicillin (1g) vs amoxicillin and clavulanate (875/125mg) aft …
Clinical effectiveness of a combination of bromhexine and amoxicillin in lower respiratory tract infection. A randomized controlled trial.
Roa CC Jr, Dantes RB. Roa CC Jr, et al. Arzneimittelforschung. 1995 Mar;45(3):267-72. Arzneimittelforschung. 1995. PMID: 7741782 Clinical Trial.
A multicenter double-blind randomized trial was performed in 22 teaching hospitals to compare the clinical effectiveness of the combination of amoxicillin (CAS 26787-78-0) plus bromhexine (CAS 3572-43-8) versus amoxicillin alone given 4 times a day for 5 to 7 days i …
A multicenter double-blind randomized trial was performed in 22 teaching hospitals to compare the clinical effectiveness of the combination …
Efficacy of modified esomeprazole-amoxicillin dual therapies for Helicobacter pylori infection: an open-label, randomized trial.
Zhang Y, Zhu YJ, Zhao Z, Zhao JT, Wang TY, Yang J, Chen DF, Lan CH. Zhang Y, et al. Eur J Gastroenterol Hepatol. 2020 May;32(5):563-568. doi: 10.1097/MEG.0000000000001646. Eur J Gastroenterol Hepatol. 2020. PMID: 31851093 Clinical Trial.
OBJECTIVE: The prevalence of Helicobacter pylori resistance to amoxicillin was less than 5% in most countries. Proton pump inhibitor (PPI)-amoxicillin dual therapy dosing four times daily (q.i.d.) for 14 days could achieve an eradication rate of more than 85%. ...PA …
OBJECTIVE: The prevalence of Helicobacter pylori resistance to amoxicillin was less than 5% in most countries. Proton pump inhibitor …
Amoxicillin and metronidazole as an adjunctive treatment in generalized aggressive periodontitis at initial therapy or re-treatment: a randomized controlled clinical trial.
Griffiths GS, Ayob R, Guerrero A, Nibali L, Suvan J, Moles DR, Tonetti MS. Griffiths GS, et al. J Clin Periodontol. 2011 Jan;38(1):43-9. doi: 10.1111/j.1600-051X.2010.01632.x. Epub 2010 Nov 10. J Clin Periodontol. 2011. PMID: 21062335 Clinical Trial.
BACKGROUND: Previously, we showed that systemic metronidazole and amoxicillin significantly improved the outcomes of non-surgical debridement in generalized aggressive periodontitis patients. ...
BACKGROUND: Previously, we showed that systemic metronidazole and amoxicillin significantly improved the outcomes of non-surgical deb …
Comparative United States and European trials of loracarbef in the treatment of acute otitis media.
Foshee WS, Qvarnberg Y. Foshee WS, et al. Pediatr Infect Dis J. 1992 Aug;11(8 Suppl):S12-9. doi: 10.1097/00006454-199208001-00003. Pediatr Infect Dis J. 1992. PMID: 1513607 Review.
Two multicenter randomized controlled clinical trials were conducted to assess the relative safety and efficacy of loracarbef and either amoxicillin/clavulanate or amoxicillin in the treatment of acute otitis media. ...Loracarbef and amoxicillin displayed com …
Two multicenter randomized controlled clinical trials were conducted to assess the relative safety and efficacy of loracarbef and either …
3,322 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page